Virtual Library
Start Your Search
Yuko Minami
Author of
-
+
P2.02 - Biology/Pathology (ID 616)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
- Presentations: 1
- Moderators:
- Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.02-073 - Cytoplasmic Mislocalization of ECT2 Protein Is Associated with Poor Prognosis in Lung Adenocarcinoma (ID 8430)
09:30 - 16:00 | Author(s): Yuko Minami
- Abstract
Background:
Lung cancer is the most lethal malignancy in worldwide. We have previously compared genetic abnormality profiles in early-stage lung adenocarcinoma using array-comparative genomic hybridization (CGH) and found that Epithelial cell transforming sequence 2 (ECT2) amplification and overexpression a new prognostic marker in early-stage lung adenocarcinoma (Cancer Science, 2014). ECT2 is an oncogene that is overexpressed in several types of human cancer and has tumorigenic activity. ECT2 is localized in the nucleus of normal cells, and its function is associated with cytokinesis. In cancer cells, ECT2 exists in not only nucleus but also cytoplasm. However, cytoplasmic ECT2 is thought to promote tumor growth and invasion. In the present study, we aimed to explore the expression of cytoplasmic ECT2 and to assess its functional and prognostic significance in lung adenocarcinoma. First, we examined the subcellular localization of the ECT2 protein in lung adenocarcinoma cells. Subsequently, we investigated the biological significance of cytoplasmic ECT2 that mediated its phosphorylation state. Finally, we examined the clinicopathological attributes of cytoplasmic ECT2 in terms of patient outcome.
Method:
ECT2 expression was evaluated in an immortalized lung epithelial cells (PL16B) and eight lung adenocarcinoma cell lines Calu-3, A549, RERF-LC-KJ, NCI-H1650, PC-9, NCI-H23, NCI-H1975, and HCC827 using Immunoblotting, RT-PCR, Immunofluorescence, and Immunohistochemistry. In order to assess the clinicopathologic characteristics of cytoplasmic ECT2, we examined 50 cases of surgical specimens lung adenocarcinoma by immunohistochemistry. Twenty fresh scraping samples of lung adenocarcinoma were also used to evaluate the expression of Phosho-ECT2 (T790). The Kaplan–Meier method and Cox regression analyses represent the prognostic significance of cytoplasmic ECT2 in lung adenocarcinoma.
Result:
We found that ECT2 expressed in eight lung adenocarcinoma at variable degree levels. In PL16B cells, ECT2 was localized in the nucleus, whereas in lung adenocarcinoma cell lines ECT2 distributed in both the cytosol and the nucleus. Importantly, overexpression of ECT2 leads to aberrant cytoplasmic localization in lung adenocarcinoma cells. We also found that cytoplasmic ECT2 was phosphorylated and accumulated at the cell membrane in lung adenocarcinoma cell lines and surgical specimens. The phosphorylated form of ECT2 was reported to correlate with malignant attributes of lung adenocarcinoma and our clinical analysis showed that cytoplasmic ECT2 expression was significantly associated with poor outcome (OS; P=0.002, DFS; P =0.001), and was an independent prognostic factor in lung adenocarcinoma.
Conclusion:
We demonstrate that aberrant localization of ECT2 to the cytoplasm is a specific feature of lung adenocarcinoma, and provide a new potential prognostic biomarker in lung adenocarcinoma.
-
+
P2.17 - Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies (ID 718)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 1
- Moderators:
- Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.17-004 - Salvage Surgery for Pulmonary Metastases in Patients with Testicular Germ Cell Tumors (ID 10054)
09:30 - 16:00 | Author(s): Yuko Minami
- Abstract
Background:
Germ cell tumors of testicular origin are the most common malignancy in young males. The lungs and the retroperitoneal space are frequently the initial sites of metastatic disease. Salvage surgery is an important treatment modality for residual post-chemotherapy pulmonary masses. We analyzed the prognostic predictors of survival in the patients after pulmonary metastasectomy.
Method:
Between September 1989 and December 2015, 32 patients underwent pulmonary resection of thoracic metastases following cisplatin-based chemotherapy. Germ cell tumors of mediastinal origin were excluded. These patients’ records were subsequently reviewed.
Result:
All patients underwent high orchidectomy and cisplatin-based chemotherapy. The primary tumor histology demonstarated 2 seminomas and 30 nonseminomatous germ cell tumors. Twenty-three patients (72%) received two or more chemotherapy regimens. International Germ Cell Cancer Collaborative Group classification, TNM factors, and serum tumor marker level at diagnosis were not associated with prognosis after pulmonary metastasectomy. The mean age at pulmonary surgery was 31.9 years. The surgical procedures included wedge resection in 23 (72%) and segmentectomy/lobectomy in 9 (28%). There were no perioperative deaths and major postoperative complications. The overall 5-year survival rate was 73% after an average follow-up of 55 months. The pathology of residual pulmonary masses revealed viable tumor cells in 12 patients (38%), necrosis alone in 18 patients (56%), and mature teratoma alone in 2 patients (6%). Preoperative increased lactic dehydrogenase (LDH) levels were significantly associated with the viable tumor cells of residual masses. The size of pulmonary metastases has not been found to be statistically related to malignant tumor cells. A significantly poor survival was observed using univariate analysis in patients with preoperative high free-βHCG (p=0.012), high intact HCG (p=0.031), high LDH (p<0.001), removing 5 or more lung metastases(p=0.012), and viable tumor cells of residual masses (p=0.026).
Conclusion:
We conclude that pulmonary resection in metastatic testicular tumors is a safe and effective treatment strategy. Increased tumor marker levels, free-βHCG/intact HCG or LDH, removing 5 or more lung metastases, and viable tumor cells of residual masses were identified as prognosis-related criteria for a poor prognosis.
-
+
SH 02 - WCLC 2017 Highlights of the Previous Day (ID 752)
- Event: WCLC 2017
- Type: Scientific Highlights
- Track: Biology/Pathology
- Presentations: 1
- Moderators:
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 503
-
+
SH 02.03 - Biology/Pathology, Mesothelioma and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies (ID 10929)
07:00 - 08:00 | Presenting Author(s): Yuko Minami
- Abstract
- Presentation
Abstract not provided
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
